---

---

symbols : NVSEF   

save search

---

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-12-12 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 12.06% | O: 5.03% H: 0.0% C: -3.82%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
TMO | News | $577.39 0.49% 0.0% 2M |

Health Technology

| 15.08% | O: 0.86% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.62% | O: 0.45% H: 0.75% C: 0.46%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 12.4% | O: 0.59% H: 1.23% C: 1.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.31% | O: 0.43% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 11.57% | O: 1.54% H: 0.06% C: -0.78%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.51% | O: 1.83% H: 0.04% C: -1.13%
growing growth market

---

US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.62% | O: 0.45% H: 0.75% C: 0.46%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.51% | O: 1.83% H: 0.04% C: -1.13%
kidney cancer novartis diagnostics therapeutics market

---

Low-Density Lipoprotein Test Global Market Report 2023, By Product Type (LDL-C; LDL-P; LDL-B) , By Component, By Disease Type, By Distribution Channel and By End User
Published: 2023-12-11 (Crawled : 17:00) - prnewswire.com
QGEN | $41.52 -0.88% 0.0% 820K |

Health Technology

| 0.19% | O: -0.02% H: 0.9% C: 0.77%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 2.66% | O: 0.75% H: 0.55% C: 0.27%
DHR | $250.41 -1.07% -0.72% 3.3M |

Health Technology

| 16.38% | O: 0.27% H: 1.66% C: 1.5%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 3.19% | O: 0.09% H: 0.0% C: 0.0%
QGEN | $41.52 -0.88% 0.0% 820K |

Health Technology

| 0.19% | O: -0.02% H: 0.9% C: 0.77%
disease report test distribution global market

---

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma
Published: 2023-12-11 (Crawled : 13:00) - globenewswire.com
ERAS | $1.88 -2.59% -2.66% 530K |

| 3.21% | O: 1.07% H: 0.0% C: -2.65%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 2.66% | O: 0.75% H: 0.55% C: 0.27%
fda melanoma granted designation advanced

---

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
Published: 2023-12-11 (Crawled : 07:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 2.66% | O: 0.75% H: 0.55% C: 0.27%
novartis study

---

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 2.66% | O: 0.75% H: 0.55% C: 0.27%
fabhalta novartis trial results

---

S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2023 Review Results
Published: 2023-12-08 (Crawled : 23:00) - prnewswire.com
TCEHY | News | $42.48 0.04% 4.3M |

Information

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
TCTZF | News | $42.5912 2.11% 40K |

Technology Services

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| Email alert Add to watchlist
SPGI | News | $413.28 0.01% 0.0% 3.1M |

Commercial Services

| Email alert Add to watchlist
DNOW | $14.77 -2.51% 0.0% 740K |

Distribution Services

| Email alert Add to watchlist
jones review results

---

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published: 2023-12-08 (Crawled : 16:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -8.07% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 3.05% | O: 0.19% H: 0.35% C: 0.2%
kisqali breast risk novartis

---

Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| 60.0% | O: -20.0% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
PPCB | $0.0011 -41.86% 5.6M |

Manufacturing

| -88.7% | O: 0.0% H: 2.61% C: -4.35%
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -8.07% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 3.05% | O: 0.19% H: 0.35% C: 0.2%
active market

---

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published: 2023-12-08 (Crawled : 14:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -8.07% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 3.05% | O: 0.19% H: 0.35% C: 0.2%
kisqali breast risk novartis

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -23.05% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 4.05% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -22.59% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -5.22% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $126.16 -1.93% -0.23% 3.1M |

Health Technology

| 32.88% | O: -0.42% H: 0.67% C: 0.25%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 3.05% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -4.05% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 25.99% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -2.33% | O: 0.2% H: 0.55% C: 0.1%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 14.72% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.93% | O: 1.07% H: 0.0% C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M |

Health Technology

| -14.12% | O: 0.08% H: 1.45% C: 1.17%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.82% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

FDA Approves Bio-Thera Solutions' Avzivi® (bevacizumab-tnjn), a biosimilar referencing Avastin®
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.87% | O: -0.97% H: 0.3% C: -0.19%
avzivi fda biosimilar

---

Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 2.32% | O: -1.66% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.87% | O: -0.97% H: 0.3% C: -0.19%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.6% | O: -1.61% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 16.97% | O: 1.97% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.71% | O: -1.19% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K |

Health Technology

| 8.56% | O: 0.51% H: 1.22% C: 1.09%
IMNM | $14.28 -2.59% -2.66% 560K |

Health Technology

| 86.99% | O: -0.64% H: 1.67% C: -1.16%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -17.4% | O: 1.67% H: 0.91% C: 0.57%
antibody therapeutics market

---

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 10.33% | O: 1.64% H: 0.0% C: -1.33%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.95% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 13.52% | O: -0.03% H: 0.28% C: -0.41%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 26.79% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 17.27% | O: 0.26% H: 0.0% C: 0.0%
DNLI | $15.55 -3.48% -3.6% 940K |

Health Technology

| -13.11% | O: 0.05% H: 5.74% C: 3.18%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -15.85% | O: 0.42% H: 2.37% C: 1.45%
disease parkinson's revenue research therapeutics market

---

Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Published: 2023-12-06 (Crawled : 00:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.95% | O: 0.52% H: 0.18% C: -0.43%
fabhalta fda first approval offering novartis

---

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 10.33% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 11.57% | O: 1.51% H: 0.13% C: -1.68%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 1.95% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 13.52% | O: -0.03% H: 0.28% C: -0.41%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| 14.58% | O: 0.14% H: 0.78% C: 0.22%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 17.27% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 10.69% | O: 0.73% H: 0.06% C: -1.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.99% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News S | $159.18 0.58% 0.58% 22M |

Technology Services

| 21.73% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 21.65% | O: 1.97% H: 0.0% C: 0.0%
ADBE A | $477.11 0.89% 0.88% 2M |

Technology Services

| -21.47% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

---

Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -19.35% | O: 0.26% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 6.2% | O: -2.6% H: 1.1% C: -1.18%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 0.37% | O: 0.27% H: 0.12% C: 0.12%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -1.99% | O: -1.1% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -21.57% | O: 0.0% H: 0.5% C: 0.17%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -0.13% | O: -1.86% H: 0.34% C: -0.19%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 12.59% | O: -1.01% H: 0.39% C: 0.19%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 18.24% | O: 0.51% H: 0.68% C: 0.32%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.59% | O: -0.5% H: 0.0% C: 0.0%
GLMD | $0.3852 6.59% 6.18% 52K |

Health Technology

| -7.67% | O: 0.03% H: 2.44% C: -1.03%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.37% | O: -0.25% H: 0.05% C: -0.37%
america market

---

Smart Inhaler Technology Market size to grow by USD 46.37 million from 2022-2027, North America to account for 37% of market growth - Technavio
Published: 2023-12-01 (Crawled : 00:20) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
RMD | $183.78 -0.24% 0.0% 970K |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
IFNNF | $32.69 -2.1% 1.2K |

Electronic Technology

| Email alert Add to watchlist
IFNNY | $32.23 -2.12% 450K |

Manufacturing

| Email alert Add to watchlist
america smart technology growth market

---

Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published: 2023-12-01 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
BHC | $8.56 0.35% 0.0% 2M |

Health Technology

| Email alert Add to watchlist
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
BCLI A | $0.5339 1.7% 1.67% 190K |

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
disease companies health therapeutics market

---

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -19.29% | O: 3.87% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -0.54% | O: 1.48% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -21.96% | O: -3.37% H: 4.51% C: 4.51%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 0.98% | O: -0.25% H: 0.68% C: 0.48%
ORTX | $16.7 0.0% 370K |

Health Technology

| 2.53% | O: -0.09% H: 0.0% C: 0.0%
GBIO | News | $2.995 -8.13% -8.85% 110K |

Health Technology

| 188.5% | O: 0.0% H: 38.05% C: 23.01%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -17.47% | O: -0.06% H: 0.35% C: 0.29%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 1.45% | O: 0.12% H: 0.97% C: 0.92%
ADAP | $1.085 -4.83% -5.07% 780K |

Health Technology

| 128.0% | O: -5.76% H: 16.36% C: 15.07%
ABEO | News | $3.165 -7.19% -7.74% 2.2M |

Health Technology

| -30.97% | O: -2.43% H: 0.0% C: 0.0%
research growing therapy market

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---